Globus Medical (GMED) Long-Term Deferred Tax (2011 - 2026)

Globus Medical has reported Long-Term Deferred Tax for 15 years, with the latest figure at $214.8 million in Q1 2026.

• For the quarter ending Q1 2026, Long-Term Deferred Tax rose 84.13% year-over-year to $214.8 million; the trailing twelve-month figure through Mar 2026 stood at $214.8 million (up 84.13% YoY), and the FY2025 full-year result was $218.2 million, up 131.65% from the prior year.
• Long-Term Deferred Tax for Q1 2026 stood at $214.8 million, down from $218.2 million in the prior quarter.
• The five-year high for Long-Term Deferred Tax was $275.9 million in Q2 2025, with the low at $7.3 million in Q3 2023.
• Historically, Long-Term Deferred Tax has averaged $89.2 million across 5 years, with a median of $48.8 million in 2022.
• Annual changes were most pronounced in 2023 — Long-Term Deferred Tax slumped 83.64% — and 2025, when it jumped 1416.0%.
• Globus Medical's Long-Term Deferred Tax stood at $48.8 million in 2022, then tumbled by 78.12% to $10.7 million in 2023, then soared by 781.61% to $94.2 million in 2024, then jumped by 131.65% to $218.2 million in 2025, then slipped by 1.56% to $214.8 million in 2026.
• The last three Long-Term Deferred Tax figures came in at $214.8 million (Q1 2026), $218.2 million (Q4 2025), and $232.4 million (Q3 2025), per Business Quant data.